India, China Pharmaceutical Companies Face Increasing Scrutiny In Washington — Forbes

COL (Join to see)
"The pandemic revealed gaping holes in U.S. supply chains. Everyone knows it. Anything medical-related was front and center when it came to critical items missing in action. The country’s over-reliance on China and India, especially for medical supplies, namely key generic drugs, is getting Washington’s attention. Little has been done to counter it so far. That is likely to change.

A poll by Morning Consult conducted on behalf of the newly formed advocacy group Americans for Safe Drugs showed that 85% of respondents said they were concerned about the drug industry’s reliance on India and China. Another 70% said that the U.S. should not be reliant on foreign sources for key generic drugs.

That reliance is stark. The U.S. imports around two-thirds of its generic medicine needs, and nearly 90% of generic APIs came from labs overseas.

Main Street understands the anecdotal evidence of the supply chain mess.

Remember when we all had to wear masks and no one could buy them, so they made semi-useless ones out of fabrics instead because China was the go-to manufacturer of N95s and the kind of masks you might see your dental hygienist wearing. Generic drugs are a more serious issue."...